Mycoplasma genitalium: A comparative genomics study of metabolic pathways for the identification of drug and vaccine targets

Infection, Genetics and Evolution

Volumn 12, Issue 1, 2012, Pages 53-62

  Butt, Azeem Mehmood ^a   Tahir, Shifa ^b   Nasrullah, Izza ^b   Idrees, Muhammad ^a   Lu, Jun ^c   Tong, Yigang ^d  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Antibiotics; Computational comparative genomics; Drug targets; Metabolic pathways; Mycoplasma genitalium; Subtractive genomics

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BACTERIAL VACCINE; FOLIC ACID; THIAMINE;

ARTICLE; BACTERIUM ISOLATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG IDENTIFICATION; GENOMICS; MOLECULAR WEIGHT; MYCOPLASMA GENITALIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS;

ALANINE-TRNA LIGASE; AMINO ACYL-TRNA SYNTHETASES; ANTI-BACTERIAL AGENTS; ARGININE-TRNA LIGASE; BACTERIAL PROTEINS; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; GENOMICS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MYCOPLASMA GENITALIUM; PROTEOMICS;

MYCOPLASMA GENITALIUM;

EID: 83555179128     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.10.017     Document Type: Article

References (63)

1. Abadio A.K., Kioshima E.S., Teixeira M.M., Martins N.F., Maigret B., Felipe M.S. Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genomics 2011, 12:75.
2. Aguero F., Al-Lazikani B., Aslett M., Berriman M., Buckner F.S., Campbell R.K., Carmona S., Carruthers I.M., Chan A.W., Chen F., Crowther G.J., Doyle M.A., Hertz-Fowler C., Hopkins A.L., McAllister G., Nwaka S., Overington J.P., Pain A., Paolini G.V., Pieper U., Ralph S.A., Riechers A., Roos D.S., Sali A., Shanmugam D., Suzuki T., Van Voorhis W.C., Verlinde C.L. Genomic-scale prioritization of drug targets: the TDR targets database. Nat. Rev. Drug. Discov. 2008, 7:900-907.
3. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
4. Amineni U., Pradhan D., Marisetty H. In silico identification of common putative drug targets in <i>Leptospira interrogans</i>. J. Chem. Biol. 2010, 3:165-173.
5. Amineni U., Pradhan D., Marisetty H. In silico identification of common putative drug targets in Leptospira interrogans. J. Chem. Biol. 2010, 3:165-173.
6. Anagrius C., Lore B., Jensen J.S. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Trans. Infect. 2005, 81:458-462.
7. Barh D., Kumar A. In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae. In Silico Biol. 2009, 9:225-231.
8. Begley T.P., Downs D.M., Ealick S.E., McLafferty F.W., Van Loon A.P., Taylor S., Campobasso N., Chiu H.J., Kinsland C., Reddick J.J., Xi J. Thiamin biosynthesis in prokaryotes. Arch. Microbiol. 1999, 171:293-300.
9. Bernstein F.C., Koetzle T.F., Williams G.J., Meyer E.F., Brice M.D., Rodgers J.R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank. A computer-based archival file for macromolecular structures. Eur. J. Biochem. 1977, 80:319-324.
10. Boeckmann B., Bairoch A., Apweiler R., Blatter M.C., Estreicher A., Gasteiger E., Martin M.J., Michoud K., O'Donovan C., Phan I., Pilbout S., Schneider M. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003, 31:365-370.
11. Bradshaw C.S., Jensen J.S., Tabrizi S.N., Read T.R., Garland S.M., Hopkins C.A., Moss L.M., Fairley C.K. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg. Infect. Dis. 2006, 12:1149-1152.
12. Caffrey C.R., Rohwer A., Oellien F., Marhofer R.J., Braschi S., Oliveira G., McKerrow J.H., Selzer P.M. A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS One 2009, 4:e4413.
13. Cheng A.C., Coleman R.G., Smyth K.T., Cao Q., Soulard P., Caffrey D.R., Salzberg A.C., Huang E.S. Structure-based maximal affinity model predicts small-molecule druggability. Nat. Biotechnol. 2007, 25:71-75.
14. Chhabra G., Sharma P., Anant A., Deshmukh S., Kaushik H., Gopal K., Srivastava N., Sharma N., Garg L.C. Identification and modeling of a drug target for Clostridium perfringens SM101. Bioinformation 2010, 4:278-289.
15. Chong C.E., Lim B.S., Nathan S., Mohamed R. In silico analysis of Burkholderia pseudomallei genome sequence for potential drug targets. In Silico Biol. 2006, 6:341-346.
16. Cohen C.R., Manhart L.E., Bukusi E.A., Astete S., Brunham R.C., Holmes K.K., Sinei S.K., Bwayo J.J., Totten P.A. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002, 359:765-766.
17. Crowther G.J., Shanmugam D., Carmona S.J., Doyle M.A., Hertz-Fowler C., Berriman M., Nwaka S., Ralph S.A., Roos D.S., Van Voorhis W.C., Aguero F. Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl. Trop. Dis. 2010, 4:e804.
18. Du Q., Wang H., Xie J. Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets?. Int. J. Biol. Sci. 2011, 7:41-52.
19. Duffield M., Cooper I., McAlister E., Bayliss M., Ford D., Oyston P. Predicting conserved essential genes in bacteria: in silico identification of putative drug targets. Mol. Biosys. 2010, 6:2482-2489.
20. Falk L., Fredlund H., Jensen J.S. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Trans. Infect. 2003, 79:318-319.
21. Fraser C.M., Gocayne J.D., White O., Adams M.D., Clayton R.A., Fleischmann R.D., Bult C.J., Kerlavage A.R., Sutton G., Kelley J.M., Fritchman R.D., Weidman J.F., Small K.V., Sandusky M., Fuhrmann J., Nguyen D., Utterback T.R., Saudek D.M., Phillips C.A., Merrick J.M., Tomb J.F., Dougherty B.A., Bott K.F., Hu P.C., Lucier T.S., Peterson S.N., Smith H.O., Hutchison C.A., Venter J.C. The minimal gene complement of Mycoplasma genitalium. Science 1995, 270:397-403.
22. Gallant P., Finn J., Keith D., Wendler P. The identification of quality antibacterial drug discovery targets: a case study with aminoacyl-tRNA synthetases. Exp. Opin. Therap. Targ. 2000, 4:1-9.
23. Galperin M.Y., Koonin E.V. Searching for drug targets in microbial genomes. Curr. Opin. Biotechnol. 1999, 10:571-578.
24. Gardy J.L., Brinkman F.S. Methods for predicting bacterial protein subcellular localization. Nat. Rev. Microbiol. 2006, 4:741-751.
25. Gibson D.G., Benders G.A., Andrews-Pfannkoch C., Denisova E.A., Baden-Tillson H., Zaveri J., Stockwell T.B., Brownley A., Thomas D.W., Algire M.A., Merryman C., Young L., Noskov V.N., Glass J.I., Venter J.C., Hutchison C.A., Smith H.O. Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science 2008, 319:1215-1220.
26. Glass J.I., Assad-Garcia N., Alperovich N., Yooseph S., Lewis M.R., Maruf M., Hutchison C.A., Smith H.O., Venter J.C. Essential genes of a minimal bacterium. Proc. Natl. Acad. Sci. U S A 2006, 103:425-430.
27. Gotoh Y., Eguchi Y., Watanabe T., Okamoto S., Doi A., Utsumi R. Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr. Opin. Microbiol. 2010, 13:232-239.
28. Hamasuna R., Osada Y., Jensen J.S. Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR. Antimicrob. Agents Chemother. 2005, 49:4993-4998.
29. Holman A.G., Davis P.J., Foster J.M., Carlow C.K., Kumar S. Computational prediction of essential genes in an unculturable endosymbiotic bacterium, Wolbachia of Brugia malayi. BMC Microbiol. 2009, 9:243.
30. Hurdle J.G., O'Neill A.J., Chopra I. Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents. Antimicrob. Agents Chemother. 2005, 49:4821-4833.
31. Hyde J.E. Exploring the folate pathway in Plasmodium falciparum. Acta Tropica 2005, 94:191-206.
32. Ibba M., Soll D. Aminoacyl-tRNA synthesis. Annu. Rev. Biochem. 2000, 69:617-650.
33. Jensen J.S. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J. Eur. Acad. Dermatol. Venereol. 2004, 18:1-11.
34. Jensen J.S. Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis. Dan. Med. Bull. 2006, 53:1-27.
35. Jensen J.S., Bradshaw C.S., Tabrizi S.N., Fairley C.K., Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin. Infect. Dis. 2008, 47:1546-1553.
36. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38:D355-360.
37. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K.F., Itoh M., Kawashima S., Katayama T., Araki M., Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006, 34:D354-357.
38. Keller T.H., Pichota A., Yin Z. A practical view of 'druggability'. Curr. Opin. Chem. Biol. 2006, 10:357-361.
39. Knox C., Law V., Jewison T., Liu P., Ly S., Frolkis A., Pon A., Banco K., Mak C., Neveu V., Djoumbou Y., Eisner R., Guo A.C., Wishart D.S. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011, 39:D1035-1041.
40. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 2001, 305:567-580.
41. Macarron R., Mensah L., Cid C., Carranza C., Benson N., Pope A.J., Diez E. A homogeneous method to measure aminoacyl-tRNA synthetase aminoacylation activity using scintillation proximity assay technology. Anal. Biochem. 2000, 284:183-190.
42. Manhart L.E., Critchlow C.W., Holmes K.K., Dutro S.M., Eschenbach D.A., Stevens C.E., Totten P.A. Mucopurulent cervicitis and Mycoplasma genitalium. J. Infect. Dis. 2003, 187:650-657.
43. Morya V.K., Dewaker V., Mecarty S.D., Singh R. In silico analysis of metabolic pathways for identification of putative drug targets for Staphylococcus aureus. J. Comput. Sci. Syst. Biol. 2010, 3:62-69.
44. Muller I.B., Hyde J.E., Wrenger C. Vitamin B metabolism in Plasmodium falciparum as a source of drug targets. Trends Parasitol. 2010, 26:35-43.
45. Perumal D., Lim C.S., Sakharkar K.R., Sakharkar M.K. Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification. In Silico Biol. 2007, 7:453-465.
46. Pieper U., Webb B.M., Barkan D.T., Schneidman-Duhovny D., Schlessinger A., Braberg H., Yang Z., Meng E.C., Pettersen E.F., Huang C.C., Datta R.S., Sampathkumar P., Madhusudhan M.S., Sjolander K., Ferrin T.E., Burley S.K., Sali A. ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res. 2011, 39:D465-474.
47. Pohlmann J., Brotz-Oesterhelt H. New aminoacyl-tRNA synthetase inhibitors as antibacterial agents. Curr. Drug Targets Infect. Disord. 2004, 4:261-272.
48. Raczniak G., Ibba M., Soll D. Genomics-based identification of targets in pathogenic bacteria for potential therapeutic and diagnostic use. Toxicology 2001, 160:181-189.
49. Razin S., Yogev D., Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 1998, 62:1094-1156.
50. Sakharkar K.R., Sakharkar M.K., Chow V.T. A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol. 2004, 4:355-360.
51. Sassetti C.M., Boyd D.H., Rubin E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 2003, 48:77-84.
52. Settembre E., Begley T.P., Ealick S.E. Structural biology of enzymes of the thiamin biosynthesis pathway. Curr. Opin. Struct. Biol. 2003, 13:739-747.
53. Smith H.O., Blessing J.A., Vaccarello L. Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group. Gynecol. Oncol. 2002, 84:140-144.
54. Svenstrup H.F., Fedder J., Abraham-Peskir J., Birkelund S., Christiansen G. Mycoplasma genitalium attaches to human spermatozoa. Hum. Reprod. 2003, 18:2103-2109.
55. Tao J., Wendler P., Connelly G., Lim A., Zhang J., King M., Li T., Silverman J.A., Schimmel P.R., Tally F.P. Drug target validation: lethal infection blocked by inducible peptide. Proc. Natl. Acad. Sci. U S A 2000, 97:783-786.
56. Thompson, D.B., Crandall, K., Harding, S.V., Smither, S.J., Kitto, G.B., Titball, R.W., Brown, K.A., 2008. In silico analysis of potential diagnostic targets from Burkholderia pseudomallei. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1), S61-S65.
57. Tully J.G., Taylor-Robinson D., Cole R.M., Rose D.L. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981, 1:1288-1291.
58. Wang J., Sung W.K., Krishnan A., Li K.B. Protein subcellular localization prediction for Gram-negative bacteria using amino acid subalphabets and a combination of multiple support vector machines. BMC Bioinform. 2005, 6:174.
59. Yu C.S., Chen Y.C., Lu C.H., Hwang J.K. Prediction of protein subcellular localization. Proteins 2006, 64:643-651.
60. Yu N.Y., Wagner J.R., Laird M.R., Melli G., Rey S., Lo R., Dao P., Sahinalp S.C., Ester M., Foster L.J., Brinkman F.S. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 2010, 26:1608-1615.
61. Zhang R., Ou H.Y., Zhang C.T. DEG: a database of essential genes. Nucleic Acids Res. 2004, 32:D271-272.
62. Zhang S., Wear D.J., Lo S. Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells. FEMS Immunol. Med. Microbiol. 2000, 27:43-50.
63. Zuccotto F., Martin A.C., Laskowski R.A., Thornton J.M., Gilbert I.H. Dihydrofolate reductase: a potential drug target in trypanosomes and leishmania. J. Comput. Aided Mol. Des. 1998, 12:241-257.